Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer’s disease
Abstract Type 2 diabetes (T2D) is a significant risk factor for Alzheimer’s disease (AD). Despite multiple studies reporting this connection, the mechanism by which T2D exacerbates AD is poorly understood. It is challenging to design studies that address co-occurring and comorbid diseases, limiting...
Saved in:
| Main Authors: | Brendan K. Ball, Jee Hyun Park, Alexander M. Bergendorf, Elizabeth A. Proctor, Douglas K. Brubaker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Systems Biology and Applications |
| Online Access: | https://doi.org/10.1038/s41540-025-00539-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood-brain barrier biomarkers modulate the associations of peripheral immunity with Alzheimer’s disease
by: Jia-Hui Hou, et al.
Published: (2025-04-01) -
Translational opportunities and barriers for blood-based biomarkers in Alzheimer’s disease: from discovery to implementation
by: WANG Yanjiang, et al.
Published: (2025-08-01) -
Amyloid blood biomarker detects Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2018-04-01) -
Blood essential trace elements and Alzheimer’s disease biomarkers in midlife
by: Xin Wang, et al.
Published: (2025-05-01) -
Blood‐based biomarkers of Alzheimer's disease: Standardization and comprehensiveness
by: Ying Liu, et al.
Published: (2024-12-01)